Archive
All News
Every briefing, headline, and filing we've published, newest first.
The WeekDrug Channels ↗
This week, we're rerunning some popular posts while we prepare for Friday's live video webinar: 340B in 2026: …
The WeekSTAT News ↗
As the world deals with an outbreak of Ebola that has no known cure, Susan Reichle, who last year co-founded A…
The WeekAJMC ↗
Apalutamide Plus ADT Improves Outcomes in High-Risk Prostate Cancer: Mary-Ellen Taplin, MD…
The WeekBioPharma Dive ↗
Co-founded by longtime Alnylam CEO John Maraganore, City has brought a clotting disorder drug into early human…
The WeekFiercePharma ↗
The FDA is going forward with an investigation into the safety of the abortion pill mifepristone, an initiativ…
The WeekFierceBiotech ↗
Roche is paying Nurix Therapeutics $700 million upfront for rights to bexobrutideg, securing a stake in a BTK …
The WeekBriefing
Over half of eligible Medicare beneficiaries are now in Medicare Advantage, with growth concentrated in specia…
The WeekDrug Channels ↗
This week, we're rerunning some popular posts while we prepare for Friday's live video webinar: 340B in 2026: …
The WeekDrug Channels ↗
This week, we're rerunning some popular posts while we prepare for Friday's live video webinar: 340B in 2026: …
The WeekBioPharma Dive ↗
Racing the clock: How precision logistics deliver life-saving nuclear medicine.…
The WeekSTAT News ↗
"We do not lack cures. We lack the infrastructure to pay for and deliver them," writes William Padula.…
The WeekAJMC ↗
Bridging Science and Reality in Diabetes Care…
The WeekFiercePharma ↗
The company adjusted its full-year 2025 earnings to account for a legal provision of 402.5 billion JPY ($2.5 b…
The WeekFierceBiotech ↗
When it comes to turning T-cell therapies toward autoimmune diseases, CAR-Ts have been leading the way. But an…
The WeekBriefing
Three-quarters of Medicare Advantage enrollees pay no added premium in 2026, but rising out-of-pocket caps and…
The WeekSTAT News ↗
"Ebola is an unforgiving enemy," writes Tom Frieden, who led the U.S. CDC response to the 2014-2016 Ebola outb…
The WeekAJMC ↗
First FDA-Approved Inhaled Insulin for Kids Arrives With Mounting Data: Kevin Kaiserman, MD…
The WeekBioPharma Dive ↗
A possible alternative to "anti-CGRP" medications, the drug didn't meet some analysts' expectations in mid-sta…
The WeekPharmaVoice ↗
While the large pharma's new drug Cobenfy has stumbled in schizophrenia, it could find new life in Alzheimer's…
The WeekPharmaVoice ↗
From hepatitis B to melanoma, recent study results show innovative approaches are gaining ground.…
The WeekFiercePharma ↗
With a resounding unanimous vote, the U.S. Supreme Court has sided with Hikma Pharmaceuticals, ruling that its…
The WeekFierceBiotech ↗
On Thursday, the public had the first chance to air their grievances about the FDA's controversial Commissione…
The WeekBriefing
The Trump administration plans to strip job protections from around 8,000 NIH officials overseeing research gr…
The WeekDrug Channels ↗
Today's guest post comes from Stephen Hom, Co-Founder, EVP & Chief Operating Officer of RIS Rx. Drawing on RIS…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.